Surrozen, Inc. – NASDAQ:SRZNW

Surrozen stock price today

$0.02
-0.01
-47.37%
Financial Health
0
1
2
3
4
5
6
7
8
9

Surrozen stock price monthly change

+194.57%
month

Surrozen stock price quarterly change

+194.57%
quarter

Surrozen stock price yearly change

+36.69%
year

Surrozen key metrics

Market Cap
 32.53M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -18.38
Revenue
 N/A
EBITDA
 -35.44M
Income
 -37.57M
Revenue Q/Q
 N/A
Revenue Y/Y
 -66.83%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Surrozen stock price history

Surrozen stock forecast

Surrozen financial statements

Profit Margin

Surrozen, Inc. (NASDAQ:SRZNW): Profit margin
Jun 2023 0 -9.38M
Sep 2023 0 -10.44M
Dec 2023 4.14M -8.91M -214.98%
Mar 2024 0 -8.83M
SRZNW income statement history

Debt to Assets

Surrozen, Inc. (NASDAQ:SRZNW): Debt to assets
Jun 2023 63999000 8.94M 13.97%
Sep 2023 53973000 8.44M 15.64%
Dec 2023 46080000 8.14M 17.68%
Mar 2024 36716000 6.58M 17.92%
SRZNW balance sheet history

Cash Flow

Surrozen, Inc. (NASDAQ:SRZNW): Cash Flow
Jun 2023 -8.74M 17.24M 187K
Sep 2023 -10.13M 7.64M -13K
Dec 2023 -7.31M 9.5M 141K
Mar 2024 -8.74M -7K 0
SRZNW cash flow history

Surrozen alternative data

Surrozen
Employees

Surrozen, Inc. (NASDAQ:SRZNW): Employee count
Jan 2024 74
Feb 2024 74
Mar 2024 74
Apr 2024 74
May 2024 42
Jun 2024 42
Jul 2024 42

Surrozen other data

Surrozen
Insider Trading

Surrozen, Inc. (NASDAQ:SRZNW): Insider trades (number of shares)
Period Buy Sel
Dec 2022 0 289332
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BLUTT MITCHELL J MD 10 percent owner
 Warrants (right to buy) 289,332 $11.5 $3,327,318
Purchase
BLUTT MITCHELL J MD 10 percent owner
 Warrants (right to buy) 42,966 $11.5 $494,109
Purchase
BLUTT MITCHELL J MD 10 percent owner
 Warrants (right to buy) 123,700 $11.5 $1,422,550
Purchase
BLUTT MITCHELL J MD 10 percent owner
 Warrants (right to buy) 166,667 $11.5 $1,916,671
SRZNW insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Surrozen stock today?

    One share of Surrozen stock can currently be purchased for approximately $0.02.

  • When is Surrozen's next earnings date?

    Unfortunately, Surrozen's (SRZNW) next earnings date is currently unknown.

  • Does Surrozen pay dividends?

    No, Surrozen does not pay dividends.

  • How much money does Surrozen make?

    Surrozen has a market capitalization of 32.53M.

  • What is Surrozen's stock symbol?

    Surrozen, Inc. is traded on the NASDAQ under the ticker symbol "SRZNW".

  • What is Surrozen's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Surrozen?

    Shares of Surrozen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Surrozen have?

    As Jul 2024, Surrozen employs 42 workers, which is 43% less then previous quarter.

  • When Surrozen went public?

    Surrozen, Inc. is publicly traded company for more then 4 years since IPO on 10 Aug 2021.

  • What is Surrozen's official website?

    The official website for Surrozen is surrozen.com.

  • Where are Surrozen's headquarters?

    Surrozen is headquartered at 171 Oyster Point Boulevard, South San Francisco, CA.

  • How can i contact Surrozen?

    Surrozen's mailing address is 171 Oyster Point Boulevard, South San Francisco, CA and company can be reached via phone at +65 04899000.

Surrozen company profile:

Surrozen, Inc.

surrozen.com
Exchange:

NASDAQ

Full time employees:

42

Industry:

Biotechnology

Sector:

Healthcare

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are highly expressed in intestinal crypts. The company was founded in 2016 and is headquartered in South San Francisco, California.

+65 04899000
171 Oyster Point Boulevard
South San Francisco, CA 94080

CIK: 0001824893
ISIN: US86889P1176
CUSIP: 86889P117